Röhnert, Maximilian A. http://orcid.org/0000-0001-8213-2047
Kramer, Michael
Schadt, Jonas http://orcid.org/0000-0002-2687-9178
Ensel, Philipp
Thiede, Christian http://orcid.org/0000-0003-1241-2048
Krause, Stefan W. http://orcid.org/0000-0002-5259-4651
Bücklein, Veit http://orcid.org/0000-0001-7391-7280
Hoffmann, Jörg
Jaramillo, Sonia
Schlenk, Richard F.
Röllig, Christoph http://orcid.org/0000-0002-3791-0548
Bornhäuser, Martin http://orcid.org/0000-0002-5916-3029
McCarthy, Nicholas
Freeman, Sylvie http://orcid.org/0000-0003-1869-180X
Oelschlägel, Uta
von Bonin, Malte http://orcid.org/0000-0002-3828-0031
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (318488004)
Wilhelm Sander-Stiftung (2021.035.1)
MeDDrive, intramural funding, #60466
Article History
Received: 5 January 2022
Revised: 24 June 2022
Accepted: 1 July 2022
First Online: 18 July 2022
Competing interests
: CT is CEO and part ownership of AgenDix GmbH, a company performing molecular diagnostics. All other authors have nothing to disclose.